Anti-Human IL-17R

Leinco Technologies
Product Code: LEI-I-627
Product Group: Primary Antibodies
CodeSizePrice
LEI-I-627-25ug25 ug£398.00
Quantity:
LEI-I-627-100ug100 ug£659.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Mouse
Antibody Isotype: IgG1
Antibody Clonality: Monoclonal
Antibody Clone: 133617
Regulatory Status: RUO
Target Species: Human
Applications:
  • Flow Cytometry
  • Mass Cytometry (CyTOF)
  • Neutralisation
  • Western Blot (WB)
Shipping:
Ambient
Storage:
The lyophilized antibody can be stored desiccated at -20°C to -70°C for up to twelve months. The reconstituted antibody can be stored for at least four weeks at 2-8°C. For long-term storage of the reconstituted antibody aseptically aliquot into working volumes and store at -20°C to -70°C in a manual defrost freezer. Avoid repeated freeze thaw cycles. No detectable loss of activity was observed after six months.

Further Information

Conjugate/Tag/Label:
Purified No Carrier Protein
Format:
This monoclonal antibody has been 0.2 um filtered and lyophilized from modified Dulbecco's phosphate buffered saline (1X PBS) pH 7.2 - 7.3 containing 5.0% w/v trehalose with no calcium, magnesium or preservatives present.
Formulation:
This monoclonal antibody has been 0.2 um filtered and lyophilized from modified Dulbecco's phosphate buffered saline (1X PBS) pH 7.2 - 7.3 containing 5.0% w/v trehalose with no calcium, magnesium or preservatives present.
Immunogen:
Purified Recombinant Human IL-17R (Accession # Q96F46)
Long Description:
Interleukin-17 receptor (IL-17R) Type 1 transmembrane glycoprotein which binds interleukin 17. IL-17R signaling is critical for pulmonary neutrophil recruitment and host defense against Gram-negative bacteria.1 It represents a marker for the metastasizing ability of osteosarcoma.1
Target:
IL-17R

References

1. Facchini, A. et al. (2007) J clin. Research clin. oncol. 133: 1017 2. Armitage, RJ. et al.(1997) Cytokine. 9(11):794-800.

Related Products

Product NameProduct CodeSupplier 
Anti-Human IL-17 R - BiotinLEI-I-755Leinco Technologies Summary Details